Cutter Capital Management

Cutter Capital Management as of Sept. 30, 2024

Portfolio Holdings for Cutter Capital Management

Cutter Capital Management holds 27 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Gilead Sciences (GILD) 8.9 $30M 359k 83.84
Bristol Myers Squibb (BMY) 8.8 $30M 574k 51.74
Royalty Pharma Shs Class A (RPRX) 5.6 $19M 665k 28.29
Agilent Technologies Inc C ommon (A) 5.3 $18M 121k 148.48
Ultragenyx Pharmaceutical (RARE) 4.7 $16M 287k 55.55
Legend Biotech Corp Sponsored Ads (LEGN) 4.7 $16M 326k 48.73
Insmed Com Par $.01 (INSM) 4.7 $16M 216k 73.00
Eli Lilly & Co. (LLY) 4.5 $15M 17k 885.94
Regeneron Pharmaceuticals (REGN) 4.5 $15M 15k 1051.24
Harmony Biosciences Hldgs In (HRMY) 4.4 $15M 376k 40.00
Perrigo SHS (PRGO) 4.3 $15M 558k 26.23
Jazz Pharmaceuticals Shs Usd (JAZZ) 3.9 $13M 118k 111.41
Springworks Therapeutics (SWTX) 3.6 $12M 379k 32.04
Miragen Therapeutics (VRDN) 3.5 $12M 519k 22.75
Sarepta Therapeutics (SRPT) 3.1 $11M 84k 124.89
Bridgebio Pharma (BBIO) 3.0 $10M 396k 25.46
Axsome Therapeutics (AXSM) 2.8 $9.5M 106k 89.87
Agios Pharmaceuticals (AGIO) 2.4 $8.3M 187k 44.43
Iovance Biotherapeutics (IOVA) 2.4 $8.2M 876k 9.39
Intellia Therapeutics (NTLA) 2.4 $8.0M 391k 20.55
Vera Therapeutics Cl A (VERA) 2.3 $7.6M 173k 44.20
Arcellx Common Stock (ACLX) 2.2 $7.5M 90k 83.51
Avidity Biosciences Ord (RNA) 2.2 $7.4M 161k 45.93
BioCryst Pharmaceuticals (BCRX) 1.8 $6.1M 798k 7.60
Enliven Therapeutics (ELVN) 1.6 $5.3M 208k 25.54
Avadel Pharmaceuticals Com Shs (AVDL) 1.5 $5.1M 385k 13.12
Ionis Pharmaceuticals (IONS) 1.2 $3.9M 97k 40.06